No. For every WellMedr's released resources, the platform provides both equally injectable and oral dissolving tablet formats for compounded semaglutide and tirzepatide. The as soon as-day-to-day oral dissolving tablet is described by WellMedr as that contains the Lively component identified for that compounded selection in a non-injection structur